iCarTab Biotechnology is committed to the development of tumor immunotherapy technology. In response to the needs of CAR-T, antibodies, and small molecule targeted drug screening, we have constructed a number of overexpression stable cell lines that can be used in in vivo and in vitro pharmacodynamic experiments.